MXCT
Maxcyte, Inc.
$1.35
-0.07 (-4.93%)
At close · Jul 16
Market Cap
$144.61M
Shares
107,121,672
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Maher Masoud | CEO | $2,687,657 |
| Douglas Swirsky | CFO | $1,225,057 |
| Ali Soleymannezhad | Chief Commercial Officer | $1,135,169 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Maher Masoud | CEO | $3,611,298 |
| Douglas Swirsky | CFO | $1,686,574 |
| Ali Soleymannezhad | Chief Commercial Officer | $1,021,833 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Doug Doerfler | CEO | $3,136,284 |
| Douglas Swirsky | CFO | $1,189,934 |
| Maher Masoud | CEO | $890,365 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Doug Doerfler | CEO | $1,575,317 |
| Maher Masoud | CEO | $790,871 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Doug Doerfler | CEO | $2,036,924 |
| Ron Holtz | CFO | $948,332 |
| Amanda Murphy | CFO | $830,622 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Amanda Murphy | CFO | $2,778,295 |
| Doug Doerfler | CEO | $1,223,727 |